Abstract
Systemic lupus erythematosus (SLE) is a disease characterized by B-cell hyperactivity leading to auto-antibody production and deposition in target organs. Pathogenic autoantibodies are typically of the IgG class, a T-cell—dependent isotype, suggesting that the polyclonal B-cell hyperactivity in SLE is T-cell—driven. Studies of T-cell function in humans with SLE have reported a number of diverse and occasionally contradictory immunologic defects (reviewed in ref. 1). It must be kept in mind that studies using human SLE patients are complicated by several factors:
-
1.
There is variability in disease expression among patients; e.g., patients with predominantly renal disease may have different immunopathogenic mechanisms than patients with primarily central nervous system involvement.
-
2.
It is difficult to stage disease activity accurately, hindering reliable comparisons between patients.
-
3.
The effect of medications, many of which are immunosuppressive, must be taken into account.
-
4.
In most instances, studies have been done using patients with active disease; thus, it is not known whether a given defect in immune function is responsible for the initiation of SLE or is instead a consequence of the disease or its treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Handwerger, B. S., Rus, V., da Silva, L., and Via, C. S. (1994) The role of cytokines in the immunopathogenesis of lupus. Springer Semin. Immunopathol. 16, 153–180.
Wofsy, D., Ledbetter, J. A., Hendler, P. L., and Seaman, W. E. (1985) Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 134, 852–857.
Hang, L., Theofilopoulos, A. N., Balderas, R. S., Francis, S. J., and Dixon, F. J. (1984) The effect of thymectomy on lupus-prone mice. J. Immunol. 132, 1809–1813.
Santoro, T. J., Portanova, J. P., and Kotzin, B. L. (1988) The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-1pr/lpr mice. J. Exp. Med. 167, 1713, 1718.
Klinman, D. M. (1997) B-cell abnormalitites characteristic of systemic lupus erythematosus, in Dubois’ Lupus Erythematosus ( Wallace, D. G., and Hahn, B. H., eds.), Williams and Wilkins, Baltimore, pp. 195–206.
Putterman, C., Kuo, P., and Diamond, B. (1997) The structure and derivation of antibodies and autoantibodies, in Dubois’ Lupus Erythematosus ( Wallace, D. G. and Hahn, B. H., eds.), Williams and Wilkins, Baltimore, pp. 383–396.
Via, C. S. and Shearer, G. M. (1988) T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9, 207–213.
Gleichmann, E., Pals, S. T., Rolink, A. G., Radaszkiewicz, T., and Gleichmann, H. (1984) Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 5, 324–332.
Levy, R. B. and Shearer, G. M. (1979) Regulation of T-cell-mediated lympholysis by the murine major histocompatibility complex: I. Preferential in vitro responses to trinitrophenylmodified self K- and D-coded gene products in parental and F1 hybrid mouse strains. J. Exp. Med. 149, 1379–1392.
Rosenberg, A. S. and Singer, A. (1992) Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Ann. Rev. Immunol. 10, 333–358.
Mason, D. W. and Morris, P. J. (1986) Effector mechanisms in allograft rejection. Ann. Rev. Immunol. 4, 119–145.
Krensky, A. M., Weiss, A., Crabtree, G., Davis, M. M., and Parham, P. (1990) T-lymphocyte-antigen interaction in transplant rejection. N. Engl. J. Med. 322, 510–517.
Van Rappard-Van Der Veen, F. M., Kiesel, U., Poels, L., Schuler, W., Melief, C. J. M., Landegent, J., and Gleichmann, E. (1984) Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease. J. Immunol. 132, 1814–1820.
Gleichmann, E., van Elven, E. H., and Van Der Veen, P. J. W. (1982) A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12, 152–159.
Portanova, J. P., Claman, H. N., and Kotzin, B. L. (1985) Autoimmunization in murine graftvs-host disease: I. Selective production of antibodies to histones and DNA. J. Immunol. 135, 3850–3856.
van Elven, E. H., Agterberg, J., Sadel, S., and Gleichmann, E. (1981) Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex: II. Autoantibodies deposited along the basement membrane of skin and their relationship to immune-complex glomerulonephritis. J. Immunol. 126, 1684–1691.
Rolink, A. G., Gleichmann, H., and Gleichmann, E. (1983) Diseases caused by reaction of T lymphocytes to incompatible structures of the major histocompatibility complex: VII. Immune-complex glomerulonephritis. J. Immunol. 130, 209–215.
Via, C. S. (1991) Kinetics of T cell activation in acute and chronic forms of murine graftversus-host disease. J. Immunol. 146, 2603–2609.
Rus, V., Svetic, A., Nguyen, P. H., Gause, W. C., and Via, C. S. (1995) Kinetics of Thl and Th2 cytokine production during the early course of acute and chronic murine graft-vs-host disease: regulatory role of donor CD8+ T cells. J. Immunol. 155, 2396–2406.
Williamson, E., Garside, P., Bradley, J. A., and Mowat, A. M. (1996) IL-12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157, 689–699.
Morris, S. C., Cheek, R. L., Cohen, P. L., and Eisenberg, R. A. (1990) Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171, 503–517.
Theofilopoulos, A. N., Prud’homme, G. J., and Dixon, F. J. (1985) Autoimmune aspects of systemic lupus erythematosus. Concepts Immunopathol. 1, 190–218.
Landry, M. and Sams, W. M. (1973) Systemic lupus erythematosus: studies of the antibodies bound to skin. J. Clin. Invest. 52, 1871–1880.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L., Damle, K. N., and Ledbetter, J. A. (1991) CTLA-4 is a second receptor for the B cell activation antigen. J. Exp. Med. 174, 561–569.
Via, C. S., Rus, V., Nguyen, P. H., Linsley, P., and Gause, W. C. (1996) Differential effect of CTLA4Ig on murine graft-versus-host (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J. Immunol. 157, 4258–4267.
Finck, B. K., Linsley, P. S., and Wofsy, D. (1993) Murine CTLA4Ig suppresses lupus in NZB/NZW F1 mice. Arthritis Rheum. 36, S62(abstract).
Gately, M. K., Wolitzky, A. G., Quinn, P. M., and Chizzonite, R. (1992) Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143, 127–133.
Scott, P. (1993) IL-12: initiation cytokine for cell-mediated immunity Science 260, 496497.
Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., and Gately, M. K. (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505–1509.
Via, C. S., Rus, V., Gately, M. K., and Finkelman, F. D. (1994) IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J. Immunol. 153, 4040 ‘1047.
Via, C. S. and Finkelman, F. D. (1993) Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int. Immunol. 5, 565–572.
Via, C. S., Rus, V., Shustov, A., Nguyen, P., and Finkelman, F. D. (1996) Administration of anti-tumor necrosis factor (TNF) monoclonal antibody induces lupus-like autoimmunity in the parent-into-fl (P-F1) model of acute graft versus host disease. Arthritis Rheum. 39, S108.
Shustov, A., Nguyen, P., Finkelman, F., Elkon, K., and Via, C. S. (1998) Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: upregulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-y production. J. Immunol. 161, 2848–2855.
Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H., and Golstein, P. (1994) Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528–530.
Sypek, J. P., Chung, C. L., Mayor, S. E. H., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., and Schaub, R. G. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 inititates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797–1802.
Via, C. S., Morse, H. C. III, and Shearer, G. M. (1990) Altered immunoregulation and autoimmune aspects of HIV infection: relevant murine models. Immunol. Today 11, 250–255.
Via, C. S. and Shearer, G. M. (1989) Autoimmunity and the acquired immune deficiency syndrome. Curr. Opin. Immunol. 1, 753–756.
Clerici, M., Hakim, F. T., Venzon, D. J., Blatt, S., Hendrix, C. W., Shearer, G. M., and Wynn, T. A. (1993) Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91, 759–765.
Clerici, M. and Shearer, G. M. (1993) A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14, 107–111.
Clerici, M., Lucey, D. R., Berzofsky, J. A., Pinto, L. A., Wynn, T. A., Blatt, S. P., Dolan, M. J., Hendrix, C. W., Wolf, S. F., and Shearer, G. M. (1993) Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262, 1721–1724.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shustov, A., Rus, V., Nguyen, P., Via, C.S. (1999). Murine Graft-vs-Host Disease. In: Kammer, G.M., Tsokos, G.C. (eds) Lupus. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-703-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-703-1_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5686-9
Online ISBN: 978-1-59259-703-1
eBook Packages: Springer Book Archive